Spanish Order30 Nov 2020 21:06
Communiqué: "the process of what is the largest centralized purchase made by the Spanish administration in its history has been completed"
https://www.mscbs.gob.es/gabinetePrensa/notaPrensa/imagenes/TABLA301120173025717.jpg
On November 11th, the adjudication of the six first lots was announced: the 1st (non-sterile surgical treatment, inadvertent, outstanding performance), 2 (protection against biological agents, ineligible type PB, level 2), 3 ( quirúrgica no sterile desechable, high performance), 4 (protection beat against biological agents, desechable type PB, level 4), 10 (molecular test COVID-19) and the 11 (extraction kit).
The evaluation process has a very complex complex mainly of the large number of information that it has to analyze and manage: companies and products have undergone a complete evaluation to ensure the completion of the required requirements, both technical and administrative . To understand the process with all the guarantees for the participants, it is necessary to revise, contrast and ask for explanations about miles of documents presented by the participating companies.
In the evaluation process, expert experts have been appointed by the Autonomous Communities, by the Spanish Agency for Medicinal Products and Sanitary Products (AEMPS), by the Carlos III Health Institute and by the National Center for Protective Media (CNMP) dependent on the National Institute of Salud y Seguridad en el Trabajo, as well as the INGESA technical team.
As of this moment, the autonomous and national adherents' administrations can contact the adjudication companies of the five adjudicated lots to reserve the material specified. The peddlers can formalize one of the company firms the Accuerdo Marco and the company was transferred to the Office of Publications of the European Union.
This process will culminate in the next days.
Sign In
Follow the stocks
